Sebastian Ens is an associate in the Corporate practice of Paul Hastings and is based in the firm’s Frankfurt office. He focuses on M&A, joint ventures and corporate restructurings as well as on corporate, commercial and contract law. Before joining Paul Hastings in October 2018, Mr. Ens worked for a major British law firm in Frankfurt for several years. Mr. Ens is fluent in German, English, French and Portuguese.
Recent Representations
(with Paul Hastings only)
- Advised the Danish brewery group Carlsberg on the acquisition of Wernesgrüner Brauerei from Bitburger Braugruppe by Carlsberg Germany. Wernesgrüner is one of the most traditional German beer brands. The roots of the brewery can be traced back to the 15th century. The current brewery, which has been part of Bitburger Braugruppe since 2002, has an annual capacity of around 1 million hectoliters.
- Advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; Stock Code: 600196.SH, 02196.HK), one of the leading Chinese healthcare groups, in forming a strategic alliance with Biopharmaceutical New Technologies of Germany (“BioNTech”; Nasdaq: BNTX) to develop and commercialize a vaccine that prevents COVID-19 infections using BioNTech’s mRNA vaccine candidate BNT162.
- Advised Hansol Paper Co., Ltd., the largest paper manufacturer in Korea, on the sale of its European Schades and R+S group companies to U.S-based Iconex, a market leader in low-cost paper receipt and differentiated label solutions.